Author:
Salahuddin Hina,Tahir Muhammad Junaid Iqbal
Reference56 articles.
1. O’Connor A, Qasim A, O’Moráin CA (2010) The long-term risk of continuous immunosuppression using thioguanines in inflammatory bowel disease. Ther Adv Chronic Dis 1:7–16
2. Pavlovic S, Zukic B, Nikcevic G (2012) Pharmacogenomics of thiopurine S-methyltransferase: clinical applicability of genetic variants. In: Clinical applications of pharmacogenetics. IntechOpen, Rijeka
3. Coulthard S, Hogarth L (2005) The thiopurines: an update. Investig New Drugs 23:523–532
4. Elion GB (1986) Historical background of 6-mercaptopurine. Toxicol Ind Health 2:1–9
5. Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651–662
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Rise of Genomics and Personalized Medicine;Advancing Healthcare Through Personalized Medicine;2021